European Archives - Page 491 of 1059 - European Medical Journal

Edmond Chan on improving patient outcomes

Edmond Chan, Senior Director, EMEA Therapeutic Area Lead, Haematology, Janssen, discusses the MA impact on improving patient outcomes.

What's next Mr President?

As the pharmaceutical industry transitions from the Trump to the Biden era, what regulatory changes can be expected and how will a new approach to healthcare policy affect the sector?

Ensuring access to medicine for all in LMICs

Addressing global access to medicine, particularly in LMICs, poses a significant challenge. As COVID-19 vaccines are distributed, how can the pharmaceutical industry ensure they reach vulnerable populations in these countries while protecting patent rights?

Neurograins: A Novel Concept for Recording Brain Activity

Brain-computer interfaces (BCIs) allow users to communicate directly with computers or external devices using neural activity.

Newly Developed COVID-19 Test Improves Time, Cost, and Sensitivity 

Recently, scientists have explored ways to streamline the COVID-19 testing process to make it faster and more efficient. Find out more

Urology featured Image

EMJ Urology 9.1 2021

Welcome to the latest issue of EMJ Urology! We are pleased to share with you a compilation of the most recent urology highlights…

Interview: Prokar Dasgupta

Prokar Dasgupta | Foundation Professor of Surgery, King’s Health Partners, King’s College London; Honorary Consultant Urologist…

Urology featured Image

Review of the European Association of Urology (EAU) Annual Meeting 2021

HILVERSUM the modern architectural city in Netherlands was the chosen location for the live studio that hosted the European Association of Urology (EAU) virtual congress on 8th–12th July 2021…

Urology featured Image

How the COVID-19 Pandemic Changed Post-operative Infections in Urology Wards: A Retrospective Cohort Study from Urology Departments

Hospital-acquired infections represent a global healthcare crisis, contributing to patient morbidity and mortality.

Balancing Risk of Thromboembolism and Bleeding in Patients with Cancer: Selecting Anticoagulant Therapy Based on Recent Clinical Trials

Venous thromboembolism (VTE) is one of the main reasons for morbidity and mortality among patients with malignancies. In addition, in this…